I cannot understand that at this stage of Lerolimab we are only in advanced talks with one party and only for a certain market. With the potential and proofen effectiveness of Lerolimab, which is for sure well known by BP for some time now, there should be a bidding war going on for some time and we should be able to choose between different offers. Instead it seems we are depended on the outcome of one negotiation with one party. What happened in the last months/ year that it seems we have driven in a dead-end street with only one exit. How can this be? I have only one answer and this is: Nader
Those goal posts must get heavy moving them all the time!
How about holding Nader to account! He hyped that call up and even live-streamed it. He promoted it like a WWE Event!
He should deliver at six weeks or the BOD find a new CEO- you can dislike my posts all you like but I’m tired of giving Nader more time. He hasn’t earned that trust
News 
Market Data 
Discover 
